S. Kashimoto

In vitro and in vivo antibacterial activities of AT-4140, a new broad-spectrum quinolone

Shinichiro Nakamura, Akira Minami, Katsuhisa Nakata et al. · Antimicrobial Agents and Chemotherapy · 1989 · 136 citations · Full text

Bioorganic Chemistry, New Broad-spectrum Quinolone, Escherichia Coli +16

Recombinant human tumor necrosis factor — II. Antitumor effect on murine and human tumors transplanted in mice

Yasunobu Sohmura, Katsuhisa Nakata, Hisahiro Yoshida et al. · International Journal of Immunopharmacology · 1986 · 61 citations

Inflammation, Human Tumors, Cell Therapy +8

Augmented antitumor effect of recombinant human interleukin-1 alpha by indomethacin.

Katsuhisa Nakata, S. Kashimoto, Hisahiro Yoshida et al. · PubMed · 1988 · 55 citations

Immunology, Immunoediting, Immunotherapy +16

Activity of AT-2266 compared with those of norfloxacin, pipemidic acid, nalidixic acid, and gentamicin against various experimental infections in mice

Shinichi Nakamura, Katsuhisa Nakata, Hiromi Katae et al. · Antimicrobial Agents and Chemotherapy · 1983 · 28 citations · Full text

Pipemidic Acid, Immunology, Pharmacotherapy +17

In vivo antitumour efficacy of MGI-114 (6-hydroxymethylacylfulvene, HMAF) in various human tumour xenograft models including several lung and gastric tumours

Yuji Sato, S. Kashimoto, John R. MacDonald et al. · European Journal of Cancer · 2001 · 19 citations

Gastric Tumours, Tumor Biology, Several Lung +11